XLV

Health Care Select Sector SPDR

Select Sector SPDR® holding S&P 500 stocks in the Health Care sector. Component industries include Health Care Equipment & Services; and Pharmaceutical & Biotechnology. The fund seeks investment results that, before expenses, generally correspond to the price and yield performance of the benchmark index. For product information and a prospectus visit www.sectorspdr.com.


7.4%

ALTAR Score™
Trend in ALTAR Score™
Percentile: 74th

OVERWEIGHT

Recommendation
 
Fund Basics
Fund sponsorState Street Global Advisors
CategoryUS Equities
Asset classEquity
Websitelink...
Inception dateDec 22, 1998
Assets (mns)$18,567
Expense ratio13 bp
CurrencyUSD
Constituent Breakdown
No. of constituents63
Herfindahl-Hirschman Index 392
Wgt avg mkt cap (mns)$134,590
Large cap (>$10bn)99.0%
Mid cap ($2-10bn)1.1%
Small cap (<$2bn)0.0%
Developed mkts.100.0%
Emerging mkts.0.0%
Fund Structure
RegulationOpen-Ended Fund
DistributionsQuarterly
Taxation1099
Stock selectionCommittee
WeightingMarket Cap
Smart-betaNo
Derivatives-basedNo
Options availableYes
Currency hedgedNo
Fund of fundsNo
Top 10 Holdings
JOHNSON & JOHNSON 10.9 %
PFIZER INC 6.9 %
UNITEDHEALTH GROUP INC 6.9 %
MERCK & CO. INC. 6.3 %
ABBOTT LABORATORIES 4.2 %
MEDTRONIC PLC 3.8 %
ABBVIE INC 3.4 %
THERMO FISHER SCIENTIFIC INC 3.4 %
AMGEN INC 3.2 %
ELI LILLY & CO 2.8 %
Sector Breakdown
Country Exposure
UNITED STATES 95.2 %
IRELAND 4.0 %
SWITZERLAND 0.6 %
Historical Performance


Standardized Annual Returns (as of 05/31/2019)
YTD1 YR2 YR3 YR5 YR10 YRIncep.
1.3% 7.6% 8.8% 8.6% 9.5% 14.9% 7.6%
Market Correlations
versus...BetaR-squared
S&P 5000.8960%
MSCI EAFE0.7234%
MSCI Emg Mkts0.5126%
Liquidity Measures
Avg. volume (000)15,206
Turnover7.5%
Avg. Bid/Ask (% of price)0.01%
ADV of underlying (mns)$20,938
Technical Indicators
Recent close$91.66
30d moving avg.$89.30
Annualized volatility13.5%
Relative strength (RSI)55
Short interest (ETF)12.5%
Short interest (underlying)2.0%
Distributions
Total Cost of Ownership Detail
  XLV Difference
Fund expenses -- --
Bid/Ask spread -- --
Round-trip commission -- -- --
Total Cost of Ownership -- -- --

Total Cost of Ownership over Time


Assets Under Management (mns)

Money Flows (mns)

Short Interest (as % of shares outstanding)

Long Money Flows (mns)

Alternative ETFs
Ticker Fund Name Overlap
vs. XLV
Expenses
vs. XLV
ALTAR Score™
vs. XLV
IYH iShares DJ US Healthcare Sec 91.1% +30 bp -0.9%
VHT Vanguard Health Care ETF 85.6% -3 bp -1.5%
FHLC Fidelity MSCI Health Care 85.5% -5 bp -1.4%
JHMH John Hancock Multifactor Health Care 73.9% +27 bp -0.6%
IXJ iShares S&P Global Healthcare 69.3% +34 bp -0.6%
RYH Invesco S&P Equal Weight Healthcare 59.2% +27 bp -0.5%
IEHS iShares Evolved U.S. Healthcare Staples 56.3% +5 bp -1.2%
IEIH iShares Evolved U.S. Innovative Healthcare 52.1% +5 bp -2.8%
PJP Invesco Dynamic Pharmaceuticals 39.5% +44 bp +4.4%
SZNE Pacer CFRA-Stovall Equal Weight Seasonal Rotation 38.5% +47 bp -0.9%
FXH First Trust Health Care Alphadex 35.9% +50 bp -2.2%
FTXH First Trust Nasdaq Pharmaceuticals 31.9% +47 bp -3.2%
IHE iShares DJ US Pharmaceuticals 30.7% +30 bp -1.7%
GDNA Goldman Sachs Motif Human Evolution 29.0% +37 bp -6.6%
PPH VanEck Vectors Pharmaceuticals 27.6% +23 bp +3.1%
IHI iShares DJ US Medical Devices 26.8% +30 bp -3.6%
LNGR Global X Longevity Thematic 26.5% +37 bp -3.7%
SPMO Invesco S&P 500 Momentum Portfolio 26.5% 0 bp -3.1%
XPH SPDR S&P Pharmaceuticals ETF 23.4% +22 bp -0.4%
MGV Vanguard Mega Cap 300 Value 19.9% -6 bp -0.1%

Content on this tab for Individual & Professional subscribers only

Results & Estimates
  2014 2015 2016 2017 2018 2019E 2020E  
Sales per share -- -- -- -- -- -- --
  change (%) -- -- -- -- -- -- --
Earnings per share -- -- -- -- -- -- --
  change (%) -- -- -- -- -- -- --
Dividends per share -- -- -- -- -- -- --
  change (%) -- -- -- -- -- -- --
Book value per share -- -- -- -- -- -- --
  change (%) -- -- -- -- -- -- --
Return on Equity
Net Margins
EPS Revision Activity (6 mo. ago = 100%)
Compound Annual Growth Rates

Content on this tab for Individual & Professional subscribers only

Valuation Metrics
  2018 2019E 2020E
Price-to-sales --x --x --x
Price-to-earnings --x --x --x
Price-to-cash flow --x --x --x
Price-to-growth --x --x --x
Price-to-book value --x --x --x
Yield --% --% --%

Some content on this tab for Individual & Professional subscribers only

ETF Research Center Fund Rating

Our measure of an ETF's overall investment merit

ALTAR Score™

XLV

7.4%

Cat. Avg

5.9%

Fund Category: US Equities

Avg. Return on Equity--%
Divided by: Fwd. P/BV--x
Less: Expenses-- bp
Equals: ALTAR Score™7.4%
Recommendation

OVERWEIGHT

Above average appreciation potential. A rating of OVERWEIGHT is assigned to ETFs with ALTAR Scores in the 4th quintile (ranking higher than 60%-80%) of their category. Typically, funds in this category consist of stocks trading at attractive valuations and/or having above-average fundamentals.

Category Overview
There are 681 funds in the US Equities category, with an average ALTAR Score™ of 5.9% and a standard deviation of 2.3%. XLV's ALTAR Score™ is approximately 0.6 standard deviations above the category average. This places XLV in the 74th percentile among funds in the category.
Consensus Recommendation

Sell-side recommendations on the ETF's individual constituents

Breakdown
Composite
XLV
Peer Average
SELL
U/W
HOLD
O/W
BUY



Recent Trends

News feed provided for free by IEX. By accessing this data you agree to abide by their Terms of Service.

 

Market Activity
Latest price
Change
Volume
Bid/Ask Spread
Update
Today's Trading

Trading data provided for free by IEX. By accessing this data you agree to abide by their Terms of Service.

 
Where to Trade XLV
Commission
on XLV1
# of Commission
-free ETFs2
 
$0.00 2,326
$0.00 2,102
$1.00 54
$4.95 500
$4.95 357
$4.95 114
$6.95 308
$6.95 291
Notes: 1. Commission of $0.00 indicates the fund is on the firm's recently published "Commission Free" list. Non-zero commissions represent each firm's standard commission rate based on our periodic review of firms' websites. Your commission may vary depending on account type and other factors. "Commission Free" ETF trades may be subject to additional requirements including minimum holding periods. 2. Not a complete list. Subject to change.
Portfolio composition files licensed from DTCC. Fundamental data for individual fund constituents sourced from FactSet Research Systems.